Fenwal is a global blood technology company dedicated to supporting transfusion medicine and cell therapies.
We help ensure the availability, safety, and effectiveness of treatments that depend on blood – medicine’s most vital natural resource. Fenwal is a Fresenius Kabi company.
FDA Clears New Plasma Protocol Software for Fenwal Alyx System Fresenius Kabi Announces $100,000 Award to Advance Research
We are all vital links in the chain of care from donor to patient. The people who commit their time and careers to transfusion medicine are making a difference on a global and local level. These are their stories.